PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
APOA1 958 Target Target ACY1 51 1 0.00 -0.99 0.02 0.68
Carcinoma 433,099 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.54
Ovarian Cancer 33,996 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.59
Stroke 146,992 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.56
Arthritis 128,324 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.57
Gout 8,355 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.63
Cholesterol 182,390 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.56
BMP-4 1,255 Target Target ACVR1B 23 1 0.01 -0.98 0.04 0.68
Hormone Replacement Therapy 11,020 Disease Target ACTG1 41 1 0.00 -0.99 0.02 0.61
Analgesia 44,857 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.56
Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 Target Target ACT-2 127 1 0.00 -1.00 0.01 0.61
Gonorrhea 5,642 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.61
CD4 112,219 Target Target ACT-2 127 1 0.00 -1.00 0.01 0.54
Cancer 1,053,491 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.49
Arrhythmia 29,330 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.57
Beta-Tubulin 4,870 Target Target ACT-2 127 1 0.00 -1.00 0.01 0.62
CD14 9,941 Target Target ACT-2 127 1 0.00 -1.00 0.01 0.60
Platelet Aggregation 25,460 Disease Target ACRP30 102 1 0.00 -1.00 0.01 0.58
CNTF 1,613 Target Target ACRP30 102 1 0.00 -0.99 0.01 0.65
Lung Cancer 91,416 Disease Target ACRP30 102 1 0.00 -1.00 0.01 0.55
Androgen Receptor 12,918 Target Target ACAT2 145 1 0.00 -1.00 0.01 0.59
Psychiatric Disorder 6,440 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.61
CCL4 5,638 Target Target ACAT2 145 1 0.00 -1.00 0.01 0.61
Prostate Cancer 71,064 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.55
Diarrhea 51,986 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.55
Schizophrenia 77,034 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.54
Cancer 1,053,491 Disease Target ACAD8 11 1 0.00 -0.95 0.09 0.54
Platelet Aggregation 25,460 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Colon Cancer 30,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Lung Cancer 91,416 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
Bronchitis 18,336 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Diabetes 332,602 Disease Target AACT 109 1 0.00 -1.00 0.01 0.52
Hormone Replacement Therapy 11,020 Disease Target AACT 109 1 0.00 -1.00 0.01 0.60
CD4 112,219 Target Target AACT 109 1 0.00 -1.00 0.01 0.54
Social Anxiety 3,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.63
Hearing Loss 30,622 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
CEA 17,022 Target Target AACT 109 1 0.00 -1.00 0.01 0.58
Osteoarthritis 36,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Anxiety 113,510 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
Prostate Cancer 71,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
Tuberculosis 146,217 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
Chronic Obstructive Pulmonary Disease 27,780 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Infection 766,637 Disease Target AACT 109 1 0.00 -1.00 0.01 0.50
CD4 112,219 Target Target A1M 59 1 0.00 -0.99 0.02 0.55
CD22 1,591 Target Target A1AT 329 1 0.00 -1.00 0.00 0.63
Epidermal Growth Factor Receptor 24,772 Target Target A1AT 329 1 0.00 -1.00 0.00 0.56
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
CD4 112,219 Target Target A1AT 329 1 0.00 -1.00 0.00 0.52
Ns3 3,189 Target Target A1AT 329 1 0.00 -1.00 0.00 0.61
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
AMBP 160 Target Target A1AT 329 1 0.00 -1.00 0.01 0.70
Alpha (Prolastin)- FDA 13 Drug Target A1AT 329 1 0.02 -0.96 0.08 0.73
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
C5a 4,164 Target Target A1AT 329 1 0.00 -1.00 0.00 0.60
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
Tuberculosis 146,217 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.51
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Kidney Diseases 4,651 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.60
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
ANGPTL4 289 Target Target A1AT 329 1 0.00 -1.00 0.00 0.69
ERK1 18,374 Target Target A1AT 329 1 0.00 -1.00 0.00 0.56
Influenza 67,933 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.53
BNP 6,842 Target Target A1AT 329 1 0.00 -1.00 0.00 0.59
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Epidermal Growth Factor Receptor 24,772 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Glucocorticoid Receptor 10,306 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
CD4 112,219 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Calmodulin 25,240 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Catechol O-Methyltransferase 2,877 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.64
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
ERK1 18,374 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.59
Adiponectin 11,994 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Phospholipase A2 13,400 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Eotaxin 2,457 Target Target 464.1 19 1 0.00 -0.97 0.05 0.66
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59